Please Support Our NICE Campaign Appeal

On 4th March 2010, NICE published their final decision not to recommend the use of azacitidine (Vidaza) to treat patients with MDS in the NHS, despite its proven ability to extend patient survival and significantly improve quality of life…

Read full story

Latest news: AML vaccine research and trial

“Scientists at King’s have developed a vaccine treatment for Leukaemia that can be used to stop the disease returning after chemotherapy or bone marrow transplant. The vaccine is due to be tested on patients for the first time. Eventually it is hoped the drug, which activates the body's own immune system against the leukaemia, could be used to treat other types of cancers. ” KCL website.

Read full story
Free donations by shopping